Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by BUYING4MEon Dec 15, 2018 8:39am
97 Views
Post# 29119304

RE:RE:RE:RE:$200,000,000 for an empty field in Jamaica.. LMFAO!?!?!?

RE:RE:RE:RE:$200,000,000 for an empty field in Jamaica.. LMFAO!?!?!?HEXO spent 80m building a 1m square foot greenhouse in Canada.  APHA spent 200m on 450k square feet in Jamaica.  

APHA could have built a greenhouse more than twice the size, for less than half the price in Canada

HEXO can ship by truck and not pay import taxes

APHA needs to ship by BOAT, or pay a super premium by Plane, offsetting any cost savings in labour

INVSTIGAT0R wrote:
Guys nobody cares. I'd rather Aphria paid 200 million for a pebble than pay 3.2 billion for Medreleaf. Why don't we start focusing on the companies that truely overpaid for assets K? Thanks bye. At least our upside isn't hindered. Imagine trying to actually realize 3.2 billion from Medreleaf. Not gonna happen. At least our LATAM gains can definitely be realized. Aphria is the best investment by far in this space right now.


Bullboard Posts